Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)
Titel:
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)
Auteur:
Hershman, Dawn L. Chen, Bingshu E. Sathe, Claire Parulekar, Wendy R. Lemieux, Julie Ligibel, Jennifer A. Gelmon, Karen A. Whelan, Timothy J. Goodwin, Pamela J.